Absence ofN-Methyl-D-Aspartate Receptor IgG Autoantibodies in Schizophrenia
Authors:
- Carolin HoffmannCHCarolin Hoffmann
- Hans C Van MierloHMHans C Van Mierlo
- Maarten J TitulaerMTMaarten J Titulaer
- Pilar Martinez-MartinezPMPilar Martinez-Martinez
- European Consortium of Autoimmune Mental Disorders (CAIMED)E(European Consortium of Autoimmune Mental Disorders (CAIMED)
Open Access
- 1 July 2015
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Psychiatry
- Vol. 72 (7) , 731-733
Abstract
This research letter investigates the presence of anti-GluN1 IgG autoantibodies in 475 patients with a schizophrenia spectrum disorder and includes the cross-vaKeywords
This publication has 4 references indexed in Scilit:
- Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective studyThe Lancet Neurology, 2014
- Prevalence of anti-N-methyl-d-aspartate (NMDA) receptor antibodies in patients with schizophrenia and related psychoses: a systematic review and meta-analysisPsychological Medicine, 2013
- Genetic Risk and Outcome of Psychosis (GROUP), a multi site longitudinal cohort study focused on gene–environment interaction: objectives, sample characteristics, recruitment and assessment methodsInternational Journal of Methods in Psychiatric Research, 2012
- Identification of a biological signature for schizophrenia in serumMolecular Psychiatry, 2011